Interleukin-8 receptor antagonists in pulmonary diseases
- 14 May 2001
- journal article
- review article
- Published by Elsevier in Current Opinion in Pharmacology
- Vol. 1 (3) , 242-247
- https://doi.org/10.1016/s1471-4892(01)00043-1
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- N‐acetylcysteine attenuates TNF‐α‐induced p38 MAP kinase activation and p38 MAP kinase‐mediated IL‐8 production by human pulmonary vascular endothelial cellsBritish Journal of Pharmacology, 2001
- Interleukin-8 Receptor (CXCR2) AntagonistsPublished by S. Karger AG ,2001
- Directed neutrophil migration to IL-8 is increased in cystic fibrosis: a study of the effect of erythromycinThorax, 2001
- Elevated serum and bronchoalveolar lavage fluid levels of interleukin 8 and granulocyte colony-stimulating factor associated with the acute chest syndrome in patients with sickle cell diseaseBritish Journal of Haematology, 2000
- EFFECTS OF RAGWEED AND Th-2 CYTOKINES ON THE SECRETION OF IL-8 IN HUMAN AIRWAY EPITHELIAL CELLSExperimental Lung Research, 2000
- Effect of inhaled endotoxin on induced sputum in normal, atopic, and atopic asthmatic subjectsThorax, 1998
- The CXC Chemokines Growth-regulated Oncogene (GRO) α, GROβ, GROγ, Neutrophil-activating Peptide-2, and Epithelial Cell-derived Neutrophil-activating Peptide-78 Are Potent Agonists for the Type B, but Not the Type A, Human Interleukin-8 ReceptorJournal of Biological Chemistry, 1996
- Chemotactic cytokines in the epidermisExperimental Dermatology, 1992
- Cloning of Complementary DNA Encoding a Functional Human Interleukin-8 ReceptorScience, 1991
- Structure and Functional Expression of a Human Interleukin-8 ReceptorScience, 1991